Published in J Exp Med on February 25, 2008
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature (2014) 3.42
Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see). Nat Rev Immunol (2014) 2.97
HLA class I binding of HBZ determines outcome in HTLV-1 infection. PLoS Pathog (2010) 1.28
Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action. Proc Natl Acad Sci U S A (2010) 1.25
Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat Biotechnol (2014) 1.22
Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog (2013) 1.21
Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands. Cell Mol Life Sci (2011) 1.11
Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry. Mol Cell Proteomics (2015) 1.05
ER stress affects processing of MHC class I-associated peptides. BMC Immunol (2009) 1.02
Impact of genomic polymorphisms on the repertoire of human MHC class I-associated peptides. Nat Commun (2014) 1.01
HLA class I allele promiscuity revisited. Immunogenetics (2011) 0.99
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi. J Proteome Res (2011) 0.94
HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII. Mol Cell Proteomics (2011) 0.93
Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules. Mol Cell Proteomics (2010) 0.92
The nature and extent of contributions by defective ribosome products to the HLA peptidome. Proc Natl Acad Sci U S A (2014) 0.92
MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther Adv Vaccines (2014) 0.91
Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes. J Virol (2009) 0.90
An open-source computational and data resource to analyze digital maps of immunopeptidomes. Elife (2015) 0.90
Activity-dependent regulation of MHC class I expression in the developing primary visual cortex of the common marmoset monkey. Behav Brain Funct (2011) 0.86
The distribution of CTL epitopes in HIV-1 appears to be random, and similar to that of other proteomes. BMC Evol Biol (2009) 0.86
Proteome sampling by the HLA class I antigen processing pathway. PLoS Comput Biol (2012) 0.85
Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands. PLoS One (2009) 0.85
The specificity and polymorphism of the MHC class I prevents the global adaptation of HIV-1 to the monomorphic proteasome and TAP. PLoS One (2008) 0.85
Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction. Immunogenetics (2009) 0.85
STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice. Cancer Immunol Immunother (2015) 0.84
Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells. J Virol (2015) 0.83
Differential ion mobility spectrometry coupled to tandem mass spectrometry enables targeted leukemia antigen detection. J Proteome Res (2014) 0.82
Higher throughput methods of identifying T cell epitopes for studying outcomes of altered antigen processing and presentation. Front Immunol (2013) 0.81
Sampling From the Proteome to the Human Leukocyte Antigen-DR (HLA-DR) Ligandome Proceeds Via High Specificity. Mol Cell Proteomics (2016) 0.80
Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers. Leukemia (2016) 0.78
The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus. Mol Cell Proteomics (2015) 0.77
T cell receptor mimic antibodies for cancer therapy. Oncoimmunology (2015) 0.77
ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules. J Immunol (2016) 0.75
Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCs. Mol Immunol (2014) 0.75
Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy. Mol Cell Proteomics (2016) 0.75
Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model. Front Pharmacol (2016) 0.75
The major histocompatibility complex class I immunopeptidome of extracellular vesicles. J Biol Chem (2017) 0.75
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
Identifying biological themes within lists of genes with EASE. Genome Biol (2003) 31.72
The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev (2002) 16.10
SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics (1999) 14.15
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (1991) 13.90
Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov (2005) 11.46
The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39
Positive and negative selection of T cells. Annu Rev Immunol (2002) 8.32
Does the ribosome translate cancer? Nat Rev Cancer (2003) 6.89
Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer (2006) 6.76
Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature (2005) 6.69
Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol (2006) 6.25
Chromosomal instability and tumors promoted by DNA hypomethylation. Science (2003) 6.02
Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science (1992) 5.99
The functional landscape of mouse gene expression. J Biol (2004) 5.65
mTOR, translation initiation and cancer. Oncogene (2006) 4.68
Peptides naturally presented by MHC class I molecules. Annu Rev Immunol (1993) 4.66
Mechanisms of MHC class I--restricted antigen processing. Annu Rev Immunol (1998) 4.54
A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat Biotechnol (2006) 4.52
Control of T cell viability. Annu Rev Immunol (2004) 3.89
A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol (2006) 3.73
How the T cell repertoire becomes peptide and MHC specific. Cell (2005) 3.39
Mass spectrometric-based approaches in quantitative proteomics. Methods (2003) 3.38
Drug discovery in the ubiquitin-proteasome system. Nat Rev Drug Discov (2006) 3.27
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01
Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol (2003) 3.00
Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J (1995) 2.84
Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem (1995) 2.76
More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov (2007) 2.68
CD8 T cell responses to infectious pathogens. Annu Rev Immunol (2001) 2.68
The DRiP hypothesis decennial: support, controversy, refinement and extension. Trends Immunol (2006) 2.42
Protein degradation and the generation of MHC class I-presented peptides. Adv Immunol (2002) 2.17
Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell (1994) 1.92
Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention. Immunity (2002) 1.74
Role of beta 2-microglobulin in the intracellular transport and surface expression of murine class I histocompatibility molecules. J Immunol (1989) 1.71
Critical role for CXCR4 signaling in progenitor localization and T cell differentiation in the postnatal thymus. J Immunol (2003) 1.63
Characterization of rapidly degraded polypeptides in mammalian cells reveals a novel layer of nascent protein quality control. J Biol Chem (2005) 1.62
Integrating epitope data into the emerging web of biomedical knowledge resources. Nat Rev Immunol (2007) 1.59
Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell response. Proc Natl Acad Sci U S A (2006) 1.58
Stress management: MHC class I and class I-like molecules as reporters of cellular stress. Immunity (2003) 1.36
New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood (2003) 1.35
Toward a definition of self: proteomic evaluation of the class I peptide repertoire. J Immunol (2004) 1.33
Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol (1993) 1.33
The turnover kinetics of major histocompatibility complex peptides of human cancer cells. Mol Cell Proteomics (2005) 1.33
A plaidoyer for 'systems immunology'. Immunol Rev (2006) 1.30
Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products. J Immunol (2006) 1.27
Distorted relation between mRNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Mol Cell Proteomics (2006) 1.26
Qa-2 molecules are peptide receptors of higher stringency than ordinary class I molecules. Nature (1993) 1.23
The final touches make perfect the peptide-MHC class I repertoire. Immunity (2007) 1.23
Identification of T-cell epitopes: rapid isolation of class I-presented peptides from viable cells by mild acid elution. J Immunother Emphasis Tumor Immunol (1993) 1.20
Minor histocompatibility antigens. Blood (1990) 1.18
Cutting edge: class I presentation of host peptides following HIV infection. J Immunol (2003) 1.18
Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes (2004) 1.17
Differential quantitative analysis of MHC ligands by mass spectrometry using stable isotope labeling. Nat Biotechnol (2004) 1.13
Restoration of a tumorigenic phenotype by beta 2-microglobulin transfection to EL-4 mutant cells. J Exp Med (1992) 1.10
The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy. Cancer Immunol Immunother (2004) 1.09
Sequence analysis and expression of an X-linked, lymphocyte-regulated gene family (XLR). J Exp Med (1987) 1.07
RhoH is important for positive thymocyte selection and T-cell receptor signaling. Blood (2006) 1.06
Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal Chem (2005) 1.05
Stable isotope tagging of epitopes: a highly selective strategy for the identification of major histocompatibility complex class I-associated peptides induced upon viral infection. Mol Cell Proteomics (2006) 0.99
Assembly of MHC class I molecules within the endoplasmic reticulum. Immunol Res (2006) 0.96
Sensory neurons with MHC-like peptide binding properties: disease consequences. Curr Opin Immunol (2006) 0.96
Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens. Eur J Immunol (2002) 0.94
Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy. Blood (2002) 0.92
Sampling of major histocompatibility complex class I-associated peptidome suggests relatively looser global association of HLA-B*5101 with peptides. Hum Immunol (2006) 0.91
Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides. Mol Cell Proteomics (2003) 0.91
Bioinformatics meets proteomics--bridging the gap between mass spectrometry data analysis and cell biology. J Bioinform Comput Biol (2003) 0.91
Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur J Immunol (2006) 0.90
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Cancer Immunol Immunother (2004) 0.89
The model B6(dom1) minor histocompatibility antigen is encoded by a mouse homolog of the yeast STT3 gene. Immunogenetics (2002) 0.88
Identification of an immunodominant mouse minor histocompatibility antigen (MiHA). T cell response to a single dominant MiHA causes graft-versus-host disease. J Clin Invest (1996) 0.88
On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens. Eur J Immunol (1997) 0.86
Changes in the lymph node microenvironment induced by oncostatin M. Blood (2003) 0.84
Duration of alloantigen presentation and avidity of T cell antigen recognition correlate with immunodominance of CTL response to minor histocompatibility antigens. J Immunol (2004) 0.84
The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome. Int Immunol (2005) 0.84
Isolation and characterization of naturally processed MHC-bound peptides from the surface of antigen-presenting cells. Methods Mol Biol (2004) 0.83
Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy. J Clin Invest (1995) 0.81
Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 3.97
Ptychographic X-ray computed tomography at the nanoscale. Nature (2010) 3.52
Biological imaging by soft x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2005) 2.79
Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation. Curr Biol (2008) 2.58
Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol (2006) 2.11
The phagosomal proteome in interferon-gamma-activated macrophages. Immunity (2009) 1.95
Fungal Rtt109 histone acetyltransferase is an unexpected structural homolog of metazoan p300/CBP. Nat Struct Mol Biol (2008) 1.89
aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO J (2007) 1.81
MHC I-associated peptides preferentially derive from transcripts bearing miRNA response elements. Blood (2012) 1.79
Quantitative biological imaging by ptychographic x-ray diffraction microscopy. Proc Natl Acad Sci U S A (2009) 1.78
A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev (2012) 1.75
ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). J Biol Chem (2010) 1.74
IL-7 receptor expression levels do not identify CD8+ memory T lymphocyte precursors following peptide immunization. J Immunol (2005) 1.72
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med (2010) 1.69
Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum (2006) 1.69
ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. EMBO J (2006) 1.63
Improvement in peptide detection for proteomics analyses using NanoLC-MS and high-field asymmetry waveform ion mobility mass spectrometry. Anal Chem (2005) 1.60
A comprehensive map of the mTOR signaling network. Mol Syst Biol (2010) 1.59
Structural heterogeneity of carbohydrate modifications affects serospecificity of Campylobacter flagellins. Mol Microbiol (2002) 1.58
Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell (2008) 1.56
Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease. Blood (2010) 1.49
Differential effects of γc cytokines on postselection differentiation of CD8 thymocytes. Blood (2012) 1.46
The exon junction complex controls the splicing of MAPK and other long intron-containing transcripts in Drosophila. Cell (2010) 1.44
H3 lysine 4 is acetylated at active gene promoters and is regulated by H3 lysine 4 methylation. PLoS Genet (2011) 1.43
Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes. Genes Dev (2010) 1.42
N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. Mol Cell Biol (2004) 1.40
Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med (2007) 1.40
Diffractive imaging of nonperiodic materials with future coherent X-ray sources. J Synchrotron Radiat (2004) 1.37
Identification of unusual bacterial glycosylation by tandem mass spectrometry analyses of intact proteins. Anal Chem (2005) 1.34
A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells. Mol Cell Proteomics (2010) 1.34
A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med (2009) 1.31
Organelle proteomics: looking at less to see more. Trends Cell Biol (2003) 1.30
MYST protein acetyltransferase activity requires active site lysine autoacetylation. EMBO J (2011) 1.29
Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem (2002) 1.24
Process outgrowth in oligodendrocytes is mediated by CNP, a novel microtubule assembly myelin protein. J Cell Biol (2005) 1.24
Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J (2009) 1.21
Phosphorylation of IRF-3 on Ser 339 generates a hyperactive form of IRF-3 through regulation of dimerization and CBP association. J Virol (2008) 1.19
Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J Biol Chem (2007) 1.19
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors. Glia (2003) 1.19
Enhanced sensitivity in proteomics experiments using FAIMS coupled with a hybrid linear ion trap/Orbitrap mass spectrometer. J Proteome Res (2009) 1.17
Regulation of the DNA damage response and gene expression by the Dot1L histone methyltransferase and the 53Bp1 tumour suppressor. PLoS One (2011) 1.16
Structural and electrostatic characterization of pariacoto virus: implications for viral assembly. Biopolymers (2009) 1.15
Modulation of the phagosome proteome by interferon-gamma. Mol Cell Proteomics (2007) 1.15
Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics (2013) 1.13
Glycopeptide specificity of the secretory protein folding sensor UDP-glucose glycoprotein:glucosyltransferase. EMBO Rep (2003) 1.13
Memory T-lymphocyte survival does not require T-cell receptor expression. Proc Natl Acad Sci U S A (2008) 1.12
Histone deacetylase inhibitors globally enhance h3/h4 tail acetylation without affecting h3 lysine 56 acetylation. Sci Rep (2012) 1.11
An enhanced mass spectrometry approach reveals human embryonic stem cell growth factors in culture. Mol Cell Proteomics (2008) 1.09
Overexpression of IL-21 promotes massive CD8+ memory T cell accumulation. Eur J Immunol (2007) 1.09
Molecular characterization of the evolution of phagosomes. Mol Syst Biol (2010) 1.08
Quantitative expression profiling guided by common retroviral insertion sites reveals novel and cell type specific cancer genes in leukemia. Blood (2007) 1.08
Cell cycle regulation of Greatwall kinase nuclear localization facilitates mitotic progression. J Cell Biol (2013) 1.08
Structure of the Rtt109-AcCoA/Vps75 complex and implications for chaperone-mediated histone acetylation. Structure (2011) 1.07
Circadian variation of the response of T cells to antigen. J Immunol (2011) 1.07
Comprehensive profiling of histone modifications using a label-free approach and its applications in determining structure-function relationships. Anal Chem (2008) 1.07
T cells targeted against a single minor histocompatibility antigen can cure solid tumors. Nat Med (2005) 1.06
Integrated microfluidic device for mass spectrometry-based proteomics and its application to biomarker discovery programs. Anal Chem (2005) 1.05
Essential role of BRG, the ATPase subunit of BAF chromatin remodeling complexes, in leukemia maintenance. Blood (2014) 1.04
The signaling protein Wnt4 enhances thymopoiesis and expands multipotent hematopoietic progenitors through beta-catenin-independent signaling. Immunity (2008) 1.04
A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics (2013) 1.04
The coming of age of phosphoproteomics--from large data sets to inference of protein functions. Mol Cell Proteomics (2013) 1.03
Occurrence and detection of phosphopeptide isomers in large-scale phosphoproteomics experiments. J Proteome Res (2012) 1.03
P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood (2002) 1.03
Drosophila S2 cells secrete wingless on exosome-like vesicles but the wingless gradient forms independently of exosomes. Traffic (2012) 1.03
Identification of glycan structure and glycosylation sites in cellobiohydrolase II and endoglucanases I and II from Trichoderma reesei. Glycobiology (2002) 1.03
The stress model of chronic pain: evidence from basal cortisol and hippocampal structure and function in humans. Brain (2013) 1.02
ER stress affects processing of MHC class I-associated peptides. BMC Immunol (2009) 1.02
Ptychographic characterization of the wavefield in the focus of reflective hard X-ray optics. Ultramicroscopy (2010) 1.01
Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway. J Biol Chem (2010) 1.01
Role of SLV in SLI substrate recognition by the Neurospora VS ribozyme. RNA (2008) 1.00
Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions. Mol Syst Biol (2013) 0.99
Selective detection and identification of sugar nucleotides by CE-electrospray-MS and its application to bacterial metabolomics. Anal Chem (2004) 0.99
Origin and plasticity of MHC I-associated self peptides. Autoimmun Rev (2011) 0.99
Wnt4 enhances murine hematopoietic progenitor cell expansion through a planar cell polarity-like pathway. PLoS One (2011) 0.98
Combined enzymatic and data mining approaches for comprehensive phosphoproteome analyses: application to cell signaling events of interferon-gamma-stimulated macrophages. Mol Cell Proteomics (2007) 0.97
Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circ Res (2002) 0.97
T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex. J Immunol (2007) 0.97
A mutant allele of the Swi/Snf member BAF250a determines the pool size of fetal liver hemopoietic stem cell populations. Blood (2010) 0.97
The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol (2011) 0.96
Kinetic characterization and identification of the acylation and glycosylation sites of recombinant human gamma-glutamyltranspeptidase. Biochemistry (2007) 0.96
T-cell generation by lymph node resident progenitor cells. Blood (2005) 0.95
Phosphorylation network rewiring by gene duplication. Mol Syst Biol (2011) 0.95
Improvement of phosphoproteome analyses using FAIMS and decision tree fragmentation. application to the insulin signaling pathway in Drosophila melanogaster S2 cells. J Proteome Res (2011) 0.94
Acute stress contributes to individual differences in pain and pain-related brain activity in healthy and chronic pain patients. J Neurosci (2013) 0.93
Structure of extended lipopolysaccharide glycoforms containing two globotriose units in Haemophilus influenzae serotype b strain RM7004. Biochemistry (2003) 0.93
Application of microfluidic devices to proteomics research: identification of trace-level protein digests and affinity capture of target peptides. Mol Cell Proteomics (2002) 0.93